Notice Number: NOT-EB-14-005

Key Dates
Release Date: August 21, 2014

Issued by
National Institute of Biomedical Imaging and Bioengineering (NIBIB)

Purpose

The purpose of this Notice is to inform potential applicants of the National Institute of Biomedical Imaging and Bioengineering (NIBIB)'s participation, effective immediately, in PA-14-308 "Platform Delivery Technologies for Nucleic Acid Therapeutics (R41/R42)."

The following sections of PA-14-308 have been updated to reflect the participation of NIBIB in this FOA:

Part 1. Overview Information

Components of Participating Organizations:
National Center for Advancing Translational Sciences (NCATS)
National Institute on Drug Abuse (NIDA)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)

Catalog of Federal Domestic Assistance (CFDA) Number(s)
93.350, 93.279, 93.286

Part 2. Section VII. Agency Contacts

Scientific/Research Contact(s)
Jessica Tucker, Ph.D. 
National Institute of Biomedical Imaging and Bioengineering (NIBIB) 
Telephone: 301-451-4778
Email: [email protected]

Financial/Grants Management Contact(s)
James Huff
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
Telephone: 301-451-4786
Email: [email protected]

All other aspects of this FOA remain the same.

Inquiries

Please direct all inquiries to:

Jessica Tucker, Ph.D.
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
Telephone: 301-451-4778
Email: [email protected]